Speaker Profile
CEO and President, PATHOMIQ
Biography
Rajat Roy is a serial entrepreneur and technology leader serving as CEO Co-founder of PathomIQ Inc. pathomiq.com With expertise spanning enterprise AIML, diagnostics, and health tech, he has led two prior successful startup exits. pathomiq.comUnder his leadership, PathomIQ has advanced its AI-powered diagnostic platform (PathomIQ_PRAD) for prostate cancer in collaboration with Myriad Genetics. myriad.gcs-web.com+1 The platform applies machine learning to analyze digital pathology images, supporting predictions of patient outcomes, treatment response, and genotypic features in 12 days. Haynes Boone+1Rajat holds educational credentials from Stanford University, and is based in the San Francisco Bay Area.
Session Abstract – PMWC 2026 Silicon Valley
Track Co-Chairs:
Gad Getz, Broad Institute
Alex Morgan, Khosla Ventures
PMWC Award Ceremony Honoree
• Greg Brockman, President & Co-Founder, OpenAI
• Steve Wozniak, Co-Founder, Apple
Keynote
• Vinod Khosla, Khosla Ventures
Target Discovery: Beyond Genomics – Revealing Hidden Layers of Biology with AI
• Keynote: Stephen Quake, CZ Biohub
• Aritro Nath, City of Hope
• Massa Shoura, Phinomics
• Omar Serang, DNAnexus
Illuminating Drug Discovery: AI Models That Learn From Biology
• Erwin Estigarribia, HEADLAMP Health
Harmonizing the Data Economy: Enabling AI Across Institutions and Therapeutic Areas
• Noah Nasser, Datma
Can AI Really Create the Next Blockbuster Drug?
• James Zou, Stanford
Interpretable AI for Biomarker Discovery: Accelerating Drug Development
• Chair: Rajat Roy, PATHOMIQ INC
Closing the Loop: AI in the Messy Middle of Drug Development
• Ari Caroline, Weave Bio
• Dina Katabi, Emerald / MIT
Is AI the New Drug?
• Michael J. Kahana, Nia Therapeutics
